Keywords
Biography
Joanne Carson is an interdisciplinary Health informatician, data scientist and infectious disease researcher interested in pharmacoepidemiology, big-data analytics, artificial intelligence and data engineering. She is an Associate Member of the International Centre for Future Health Systems.
My Grants
New South Wales Ministry of Health Grant Award: REACH-B-TX sub-study (2024; AUD $107,396.170)
My Qualifications
...view moreJoanne Carson is an interdisciplinary Health informatician, data scientist and infectious disease researcher interested in pharmacoepidemiology, big-data analytics, artificial intelligence and data engineering. She is an Associate Member of the International Centre for Future Health Systems.
My Grants
New South Wales Ministry of Health Grant Award: REACH-B-TX sub-study (2024; AUD $107,396.170)
My Qualifications
- Doctor of Philosophy (Medicine/Data Science)
 
University of New South Wales | Sydney, Australia | 2023
- Master of Public Health (Biostatistics/Epidemiology)
 
Curtin University | Perth, Australia | 2018
- Bachelor of Science (Pharmacology/Immunology)
 
University of New South Wales | Sydney, Australia | 2012
My Awards
| 
 2024  | 
 Kirby Institute Emerging Investigator Award  | 
| 
 2023  | 
 University of New South Wales Dean’s Award for Outstanding Thesis  | 
| 
 2023  | 
 Elsevier Atlas Award Winner Theme Sustainable Development Goal (SDG3), Good Health and Well-Being Publication  | 
| 
 2023  | 
 Kirby Institute Post-Graduate Student Prize  | 
| 
 2022  | 
 Top Ranked Abstract in Clinical Research- International Network on Hepatitis in Substance Users Conference, Glasgow, UK  | 
| 
 2022  | 
 Best presentation by STAToSPHERE conference, Sydney Australia  | 
My Research Activities
Leads the Pharmaco-AI Infectious Disease Surveillance (PHASE) project aiming to enhance capabilities to monitor infectious disease trends, health outcomes and health system utilisation in Australia. PHASE harnesses recent advances in national data-linkage and artificial intelligence to develop novel analytic approaches and advanced pharmacoepidemiologic surveillance systems.